Vaccine manufacturer Moderna said Wednesday the U.S. Food and Drug Administration (FDA) had approved its new influenza vaccine, nearly six months after the regulator briefly rejected an application for review. The company’s first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults ages 50 and older, the U.S.-based pharmaceutical firm said in […]
The post US regulators approve Moderna flu vaccine appeared first on Insider Paper.
